"url_bulletins","year","month","comorbidity","comorbidity_cases","comorbidity_percent"
"https://github.com/fbranda/measles/blob/main/Italy/2022/bulletins/RM_News_2022_66.pdf",2022,11,"Trombocitopenia",1,"6.67"
"https://github.com/fbranda/measles/blob/main/Italy/2022/bulletins/RM_News_2022_66.pdf",2022,11,"Cheratocongiuntivite",1,"6.67"
"https://github.com/fbranda/measles/blob/main/Italy/2022/bulletins/RM_News_2022_66.pdf",2022,11,"Insufficienza respiratoria",2,"13.33"
"https://github.com/fbranda/measles/blob/main/Italy/2022/bulletins/RM_News_2022_66.pdf",2022,11,"Polmonite",2,"13.33"
"https://github.com/fbranda/measles/blob/main/Italy/2022/bulletins/RM_News_2022_66.pdf",2022,11,"Stomatite",3,"20.00"
"https://github.com/fbranda/measles/blob/main/Italy/2022/bulletins/RM_News_2022_66.pdf",2022,11,"Diarrea",3,"20.00"
"https://github.com/fbranda/measles/blob/main/Italy/2022/bulletins/RM_News_2022_66.pdf",2022,11,"Epatite/aumento transaminasi",3,"20.00"
"https://github.com/fbranda/measles/blob/main/Italy/2022/bulletins/RM_News_2022_67.pdf",2022,12,"Diarrea",1,"5.56"
